The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus. [electronic resource]
Producer: 20080116Description: 1404-8 p. digitalISSN:- 0007-0920
- Adult
- Aged
- Ataxia Telangiectasia Mutated Proteins
- Biomarkers, Tumor -- analysis
- Biopsy, Needle
- Carcinoma, Squamous Cell -- metabolism
- Cell Cycle Proteins -- analysis
- Checkpoint Kinase 2
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- DNA-Binding Proteins -- analysis
- Disease Progression
- Drug Administration Schedule
- ErbB Receptors -- analysis
- Esophageal Neoplasms -- metabolism
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Humans
- Immunohistochemistry
- Male
- Middle Aged
- Neoadjuvant Therapy -- methods
- Predictive Value of Tests
- Prospective Studies
- Protein Serine-Threonine Kinases -- analysis
- Remission Induction
- Survival Analysis
- Treatment Outcome
- Tumor Suppressor Protein p53 -- analysis
- Tumor Suppressor Proteins -- analysis
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.